Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8348571 | Peptides | 2013 | 5 Pages |
Abstract
The aim of this study was to evaluate the transcriptomic profiling of C-type natriuretic peptide (CNP) and of its specific receptor, NPR-B in human leukocytes of heart failure (HF) patients as a function of clinical severity, assessing the possible changes with respect to healthy subjects (C). mRNA expression was evaluated by Real-Time PCR and total RNA was extracted from leukocytes of C (n = 8) and of HF patients (NYHA I-II, n = 7; NYHA III-IV, n = 13) with PAXgene Blood RNA Kit. Significantly higher levels of CNP mRNA expression were found in HF patients as a function of clinical severity (C = 0.23 ± 0.058, NYHA I-II = 0.47 ± 0.18, NYHA III-IV = 2.58 ± 0.71, p = 0.005 C vs NYHA III-IV, p = 0.017 NYHA I-II vs NYHA III-IV) and NPR-B transcript levels resulted down-regulated in HF patients with higher NYHA class (C = 2.2 ± 0.61, NYHA I-II = 2.76 ± 0.46, NYHA III-IV = 0.29 ± 0.13, p = 0.001 C vs NYHA III-IV, p < 0.0001 NYHA I-II vs NYHA III-IV). A significant negative correlation between CNP and NPR-B mRNA expression (r = 0.5, p = 0.03) was also observed. These results suggest a co-regulation of NPR-B and CNP expression supporting the relevance of this receptor in human disease characterized by a marked inflammatory/immune component and suggesting the possibility of manipulating inflammation via pharmacological agents selective for this receptor.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
M. Cabiati, L. Sabatino, R. Caruso, A. Verde, C. Caselli, T. Prescimone, D. Giannessi, S. Del Ry,